Gainers
- NuCana NCNA stock increased by 22.36% to $2.9 during Wednesday's regular session. The current volume of 77.9 million shares is 21650.59% of NuCana's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $151.2 million.
- Regencell Bioscience RGC stock moved upwards by 17.14% to $20.12. As of 12:30 EST, Regencell Bioscience's stock is trading at a volume of 130.8K, which is 13.74% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $254.4 million.
- Biophytis BPTS shares rose 15.44% to $9.15. The market value of their outstanding shares is at $115.0 million.
- Progenity PROG shares moved upwards by 13.89% to $1.01. The current volume of 9.7 million shares is 136.76% of Progenity's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $120.6 million.
- Palisade Bio PALI stock increased by 10.92% to $2.64. As of 12:30 EST, this security is trading at a volume of 735.2K shares, making up 137.96% of its average full-day volume over the last 100 days. The company's market cap stands at $34.0 million.
- Iterum Therapeutics ITRM stock rose 9.39% to $0.61. As of 12:30 EST, this security is trading at a volume of 19.8 million shares, making up 198.44% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $110.9 million.
Losers
- Editas Medicine EDIT shares decreased by 20.37% to $41.77 during Wednesday's regular session. As of 12:30 EST, Editas Medicine's stock is trading at a volume of 6.9 million, which is 344.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 billion.
- Dermata Therapeutics DRMA shares fell 18.63% to $4.09. The company's market cap stands at $34.0 million. As per the news, the Q2 earnings report came out 2 days ago.
- Sonoma Pharmaceuticals SNOA shares fell 13.29% to $6.06. Trading volume for this security as of 12:30 EST is 1.5 million, which is 56.43% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
- Altimmune ALT shares declined by 13.25% to $12.85. Trading volume for Altimmune's stock is 1.2 million as of 12:30 EST. This is 70.09% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $510.1 million.
- Ensysce Biosciences ENSC shares fell 9.98% to $3.16. Trading volume for this security as of 12:30 EST is 625.1K, which is 32.34% of its average full-day volume over the last 100 days. The company's market cap stands at $76.6 million.
- Zealand Pharma ZEAL stock decreased by 9.72% to $29.11. The market value of their outstanding shares is at $1.2 billion.
See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in